Front Oncol 2020 8;10:628367. Epub 2021 Feb 8.
Cancer & Blood Disorder Institute, Johns Hopkins All Children's Hospital, South, St. Petersburg, FL, United States.
Cancer initiation, progression, and metastasis leverage many regulatory agents, such as signaling molecules, transcription factors, and regulatory RNA molecules. Among these, regulatory non-coding RNAs have emerged as molecules that control multiple cancer types and their pathologic properties. The human microRNA-211 (MIR211) is one such molecule, which affects several cancer types, including melanoma, glioblastoma, lung adenocarcinomas, breast, ovarian, prostate, and colorectal carcinoma. Read More